Skip to main content
. 2022 Nov 1;24(11):e39748. doi: 10.2196/39748

Table 1.

Characteristics of studies included in the scoping review (n=133).

Study characteristics Studies, n (%)
Year of publicationa

2000-2017 9 (7.5)

2018 13 (9.8)

2019 21 (15.8)

2020 48 (36.1)

2021 42 (31.6)
Type of study

Clinical 62 (46.6)

Epidemiological 40 (30)

Review 15 (11.3)

Commentary 11 (8.3)

Survey and interviews 5 (3.8)
Institution typeb

Academic 121 (91)

Governmental and nongovernmental organizations 12 (9)
Type of artificial intelligence applicationc

Screening 41 (30.8)

Diagnostic 41 (30.8)

Therapeutic 15 (11.3)

Prognostic 45 (33.8)

Epidemiological 45 (33.8)
Type of cancer

General 28 (21.1)

Gynecologic 19 (14.3)

Breast 16 (12)

Oral 12 (9)

Prostate 12 (9)

Skin 12 (9)

Lung 8 (6)

Hematologic 6 (4.5)

Brain 4 (3)

Liver 4 (3)

Colorectal 3 (2.3)

Esophageal 3 (2.3)

Head and neck 2 (1.5)

Pancreatic 2 (1.5)

Gastrointestinal 1 (0.8)

Thyroid 1 (0.8)

aInclusive.

bOn the basis of affiliation of the senior author.

cTotal numbers exceed 133 due to 26 articles falling into multiple categories.